||2 years -20¡ãC Powder, 2 weeks4¡ãC in DMSO,6 months-80¡ãC in DMSO
Note: Products for research use only, not for human use
Lurasidone is a novel psychotropic agent that has been shown in studies of cloned human receptors to be an antagonist at the 5-HT2A receptor, with a binding affinity (Ki; the dissociation constant of the inhibitor) of 0.47, and a Ki of 0.99 at the D2 receptor. It also has a very high affinity For the 5-HT7 receptor, which is nearly identical to its affinity For the 5-HT2A receptor. In addition, lurasidone has moderate partial agonist effects at the 5-HT1A receptor and moderately potent antagonist effects at ¦Á2c receptor subtypes .
For the detailed information about the solubility of lurasidone in water, the solubility of lurasidone in DMSO, the solubility of lurasidone in PBS buffer, the animal experiment£¨test£© of lurasidone,the in vivo,in vitro and clinical trial test of lurasidone,the cell experiment£¨test£© of lurasidone,the IC50, EC50 and Affinity of lurasidone, please contact DC Chemicals.